Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2025-12-24 @ 4:04 PM
NCT ID:
NCT03161366
Eligibility Criteria:
Inclusion Criteria:
* Individuals aged 6 years or older will be enrolled in the study if they are a contact or contact of contact of a laboratory-confirmed Ebola virus disease case. Children aged between 1 and 6 years may also be enrolled in the study in case there is a confirmed contact with a laboratory-confirmed Ebola patient
* willing to accept weekly visits
* intending to remain in the study area for three months
* providing informed consent, and where applicable, assent
Exclusion Criteria:
* history of EVD (self-report or laboratory confirmed)
* history of having received other investigational research agents in the previous 28 days
* history of anaphylaxis to a vaccine or vaccine component (self-report)
* severe illness that makes the person bed-bound or requiring hospitalization at the time of the vaccination
* severe immunocompromised status
* history of having received immunosuppressant therapies that would substantially interfere with the mode of action of the Ebola vaccine in the previous 6 months
* unwilling to accept weekly visits
* not intending to remain in the study area for three months
* informed consent or assent not provided
* any other condition in which, in the judgment of the investigator, would interfere with or serve as a contraindication to protocol adherence, or impair the subject or caregiver's ability to give informed consent, and where applicable, assent.
* fever above 38°C
* previous receipt of rVSVΔG-ZEBOV-GP in the last 3 years or at being part of another Ebola vaccine clinical trial.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Year
Study:
NCT03161366
Study Brief:
Protocol Section:
NCT03161366